コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 D2R is a prominent target for drug treatments in disorde
2 D2R signals through distinct G-protein and beta-arrestin
3 D2R slowed the endocytosis of Ca(V)2.2 containing exon 3
4 D2R-mediated signaling in dopamine neurons is involved i
5 D2R-OE mice display deficits in cognition and motivation
6 D2Rs expressed by midbrain DA neurons function as autore
8 ty occurred within dopamine receptor type-2 (D2R)-expressing cells in the nucleus accumbens (NAc), si
11 lices from wild-type mice with quinpirole, a D2R agonist, but those changes were lacking in D2LR knoc
13 D) using positron emission tomography with a D2R-selective radioligand insensitive to endogenous dopa
14 be explained by a model that considers A2AR-D2R heteromers as heterotetramers, constituted by A2AR a
15 ock an allosteric modulation within the A2AR-D2R heteromer, by which adenosine decreases the affinity
18 suggest the primary contribution of altered D2R signaling to obesity lies in altered energy expendit
22 ne (DA) release, we retrospectively analyzed D2R availability measures of 8 current smokers, 10 ex-sm
23 as heterotetramers, constituted by A2AR and D2R homodimers, as demonstrated by experiments with biol
25 istochemistry to map dorsal-striatal D1R and D2R expression at the promoter level in postnatal day 0
27 expression and colocalization of the D1R and D2R proteins was found in clusters of neurons endemic to
28 ntial molecular interactions between D1R and D2R we also employed a recently developed proximity-liga
29 G protein signaling at DA receptors (D1R and D2R) in addition to activating their own G protein-indep
30 block dopamine D1 and D2 receptors (D1R and D2R) when the PTL was conjugated to an engineered cystei
34 ge-matched women, and measured brain MOR and D2R availability using PET with selective radioligands [
36 hanistic details of biased D2R/G-protein and D2R/beta-arrestin signaling in vivo has been challenging
38 oved predictions of structural proximity and D2R mutagenesis demonstrate that ET-MIp predicts functio
40 ly attenuated sucrose operant responding and D2R activation or blockade in the NAc bidirectionally mo
41 cocaine is necessary but not sufficient, and D2R signaling is required for the behavioral and cellula
45 2b and 22c), all showed improved affinity at D2R over 1 with neither a loss of efficacy nor an increa
46 n guanine nucleotide exchange experiments at D2R and consequently represent biased agonists favoring
47 d with dopamine D2/D3 receptor availability (D2R), no study to date has investigated the relationship
51 ns of the striatum, the beta-arrestin-biased D2R caused a significant potentiation of amphetamine-ind
52 y developed beta-arrestin2 (betaarr2)-biased D2R partial agonists to simultaneously target hyper- and
54 ipsychotic-like effects of a betaarr2-biased D2R ligand are driven through both striatal antagonism a
55 Therefore, we propose that betaarr2-biased D2R ligands that exert region-selective actions could pr
56 acquiring the mechanistic details of biased D2R/G-protein and D2R/beta-arrestin signaling in vivo ha
60 iffer significantly between groups, blocking D2Rs significantly changed the composition of the sixfol
63 xplains some of the side effects elicited by D2R blockers when used in neurological and psychiatric c
64 eating phenotype may reflect altered central D2R function better than other commonly used obesity-rel
67 a-arrestin2- or limit G protein-dependent D1/D2R signaling could represent a more mechanistically inf
68 ctions of D1 and D2 dopamine receptors (D1R, D2R), the expression of which is largely separated betwe
70 ent findings where we failed to detect a D1R-D2R PLA signal in the adult striatum, in PD0 striatum we
72 cits observed in mice with upregulated D2Rs (D2R-OEdev mice) are reversed by decreasing function of t
73 king status affects baseline dopamine D2/D3 (D2R) receptor availability and methylphenidate-induced d
78 unds of types 1-3 consist of three different D2R pharmacophores bound to an affinity-generating lipop
80 l and genetic attempts to block or eliminate D2R have led to controversial results that questioned th
81 D2 receptor (D2R) antagonist (eticlopride), D2R agonist (quinpirole), corticotropin-releasing factor
85 ng cAMP formation in cells singly expressing D2Rs but stimulating cAMP accumulation in D2R/NTS1R-coex
86 vents synaptic stimulation from facilitating D2R-induced ADPs, suggesting that this phenomenon depend
87 le and that G-protein signaling accounts for D2R canonical MAP kinase signaling cascade activation, w
89 ne and in complex with peptides derived from D2R and GRK1 reveals that the differential recognition i
91 s of alcoholic families suggesting that high D2R function may protect against alcohol dependence.
94 allenge to test the hypothesis that impaired D2R internalization in SZ leads to blunted late-phase di
97 In conclusion, the age-related decline in D2R was not linked to the age-related decline in sweetne
100 can be largely explained by the encoding in D2R-expressing NAc cells of prior unfavourable outcomes
101 nal phosphoprotein (DARPP-32) exclusively in D2R-expressing cells exhibited preferential D2R changes
103 or the altered activity of DA VTA neurons in D2R-OE mice: a reduction in the expression of distinct N
105 tein and beta-arrestin signaling pathways in D2R pharmacology, neurobiology, and associated pathologi
107 In contrast, loss of ERK/MAPK signaling in D2R-MSNs (indirect pathway) resulted in a profound hyper
109 A possible protective role of increased D2R levels in the striatum is further supported by precl
111 eclinical studies have shown agonist-induced D2R internalization can be imaged with positron emission
114 naling through the intracellularly localized D2R long isoform (D2LR) elicits extracellular signal-reg
119 ial exploration preferentially recruits mPFC D2R+ cells, but that this recruitment is attenuated in V
121 bolic impairments arising from disrupted NAc D2R signaling are involved in compulsive and perseverati
122 Collectively, these results implicate NAc D2R in regulating both peripheral glucose levels and glu
124 Postsynaptically, i.e., in striatal neurons, D2R signaling controls complex functions such as motor a
125 idol and phencyclidine indicates that normal D2R signaling homeostasis can be dramatically altered, i
126 nally, we found that blockade of D1R but not D2R activity in the DMS attenuates alcohol consumption.
128 tine, treatment mitigates the acquisition of D2R-antagonist-induced aberrant motor learning in mice.
129 ation requires the coordinated activation of D2R in the bed nucleus of the stria terminalis and the c
132 dly discovered a G protein-biased agonist of D2R, compound 1, which is the first G protein-biased D2R
134 nuing efforts to identify biased agonists of D2R, we unexpectedly discovered a G protein-biased agoni
138 f antipsychotics is triggered by blockade of D2R on cholinergic interneurons and the consequent incre
140 e in support of intrastriatal connections of D2R(+)-MSNs (iMSNs) with dMSNs and indicate that D2R sig
141 aled the overall fundamental contribution of D2R in motor functions and explains some of the side eff
142 We have developed ligands that are devoid of D2R-mediated G(i/o) protein signaling, but are simultane
145 dendritic currents and blunted the impact of D2R activation on spontaneous activity and neuronal exci
148 mouse lines with a cell-specific knockout of D2R either in MSNs (MSN-D2RKO) or in dopaminergic neuron
151 s but significantly reduced the magnitude of D2R-dependent inhibitory somatodendritic currents and bl
152 us to directly evaluate the participation of D2R in spontaneous locomotor activity and motor learning
153 intaining the excitability and plasticity of D2R-MSNs.SIGNIFICANCE STATEMENT Alterations in ERK/MAPK
154 ovides novel insight into the unique role of D2R-mediated neuronal activity to reward-associated cues
155 hese studies illuminate the critical role of D2R-mediated signaling in regulating the activity of str
157 ase is expected to enhance APD antagonism of D2Rs where and when dopaminergic transmission occurs.
159 ying a novel signaling pathway downstream of D2Rs that may contribute to prefrontal function under no
160 s beta-arrestin, we find that the effects of D2Rs on prefrontal pyramidal neurons are actually mediat
161 nistic bases for this dual signaling mode of D2Rs and how these new concepts might be leveraged for t
162 vioral investigations to uncover the role of D2Rs in hippocampal-dependent plasticity and learning.
164 that the effect of haloperidol antagonism on D2R metabolic signaling events is largely mediated by ac
165 DA neuron-specific loss of GIRK channels on D2R-dependent regulation of VTA DA neuron excitability a
168 data demonstrate that p11 located in ChAT or D2R-containing neurons is involved in regulating therape
169 ss a fluorescence marker to visualize D1R or D2R MSNs, we show that repeated cycles of systemic admin
170 tetrahydroisoquinoline head group with other D2R "privileged structures" generated orthosteric antago
173 protective role of accumbal indirect pathway D2Rs in alcohol consumption but emphasize their importan
174 tensity, and striatal D2R binding potential (D2R BPND) using positron emission tomography with a D2R-
175 D2R-expressing cells exhibited preferential D2R changes in the nucleus accumbens (NAc), a striatal r
176 , a highly overlapping population-prefrontal D2R+ neurons-plays an important role in both normal and
178 this, Evolutionary Trace was used to produce D2R mutants with strongly biased signal transduction for
179 differential effects of dopamine-2 receptor (D2R) and its agonist-induced activation on trafficking o
180 d a phenomenon whereby dopamine D2 receptor (D2R) activation elicits afterdepolarizations (ADPs) in s
183 tudies have shown that dopamine D2 receptor (D2R) antagonism, paired with a motor task, not only impa
184 ceived injections of a dopamine D2 receptor (D2R) antagonist (eticlopride), D2R agonist (quinpirole),
185 lacebo-controlled pharmacology [D2 receptor (D2R) antagonist amisulpride] in humans with resting-stat
186 chlorperazine (PCZ), a dopamine D2 receptor (D2R) antagonist approved to treat nausea, vomiting, and
187 use many APDs are dopamine (DA) D2 receptor (D2R) antagonists, such a mechanism would be particularly
188 or (MOR) and decreased dopamine D2 receptor (D2R) availability in addictive disorders, the role that
191 tin-biased agonists of dopamine D2 receptor (D2R) by extensively exploring multiple regions of aripip
192 ages one protomer of a dopamine D2 receptor (D2R) dimer in a bitopic mode to allosterically inhibit t
193 e at one protomer of a dopamine D2 receptor (D2R) dimer to negatively modulate the binding of dopamin
196 ne A2A receptor (A2AR)-dopamine D2 receptor (D2R) heteromers are key modulators of striatal neuronal
199 eport that the modulation of DA D2 receptor (D2R) signaling bidirectionally regulates the consolidati
201 function, the global effect of D2 receptor (D2R) stimulation or blockade remains highly controversia
202 s target primarily the dopamine D2 receptor (D2R) to inhibit G(i/o)-mediated adenylyl cyclase, a rece
203 ne signals through the dopamine D2 receptor (D2R) to modulate central nervous system functions throug
204 suggest impaired dopamine (DA)-D2 receptor (D2R) trafficking in patients with schizophrenia (SZ).
206 oupled receptor (GPCR) dopamine D2 receptor (D2R), regulating its internalization and surface express
207 y comprises three subtypes: the D2 receptor (D2R), with short and long isoform variants (D2SR and D2L
211 e identified a key role of D2-like receptor (D2R)-expressing neurons in response to a reward-predicti
214 sweet preferences and striatal D2 receptors (D2R) decline with age and may be altered in obesity.
215 sing dopamine D1 (D1R-MSN) vs. D2 receptors (D2R-MSN) can exert antagonistic effects in drug-related
217 mpletely lacking DA D2, D3, or D4 receptors (D2R, D3R, or D4R KO mice) and their wild-type (WT) litte
219 p layers of the mPFC, dopamine D2 receptors (D2Rs) are mainly expressed by SC neurons, and used D2-Cr
220 that selective deletion of DA D2 receptors (D2Rs) from indirect-pathway medium spiny neurons (iMSNs)
221 IGNIFICANCE STATEMENT Dopamine D2 receptors (D2Rs) in the prefrontal cortex (PFC) are thought to play
223 availability of dopamine (DA) D2 receptors (D2Rs) in the striatum is associated with high cocaine in
225 lthough partial agonists at DA D2 receptors (D2Rs), like aripiprazole, were developed to simultaneous
226 opamine D1 receptors (D1Rs) or D2 receptors (D2Rs), which drive "Go" or "No-Go" behaviors, respective
227 commonly antagonizing D2 dopamine receptors (D2Rs), on cognitive deficits and memory impairments rema
228 that activity of dopamine D2-like receptors (D2Rs) leads selectively to long-term depression (LTD) of
229 e exclusively a subset of D2-like receptors (D2Rs), whereas dopamine-mediated responses proximal to t
230 similar to most G protein-coupled receptors, D2Rs signal not only through canonical G protein pathway
233 leaving open the question of whether reduced D2R contributes to obesity through alterations in energy
235 lly, dopaminergic neurons themselves require D2R, suggesting a critical role in dopamine release via
236 pecific viral expression approach to restore D2R variants that preferentially engage either G-protein
238 ltered, indicating that targeting a specific D2R signal transduction pathway could allow for more pre
239 ception of sweetness intensity, and striatal D2R binding potential (D2R BPND) using positron emission
241 ffect of smoking status on baseline striatal D2R availability; with current smokers showing lower str
243 Nevertheless, interactions between striatal D2R and peripheral glucose have not been previously desc
245 arkers significantly predict dorsal striatal D2R in 117 healthy ethnically diverse residents of the N
247 e show that manipulations involving striatal D2R signaling coincide with perseverative and impulsive-
248 nce ex-smokers may recover from low striatal D2R availability and from increased behavioral aggressio
249 with current smokers showing lower striatal D2R availability compared with nonsmokers (caudate, puta
253 nts with SZ and HC, suggesting that striatal D2R internalization as measured by our imaging paradigm
257 first report of serum antibodies to surface D2R and NR1 in pediatric patients with isolated psychosi
259 D2R is reduced in obesity and that the TaqA1 D2R variant may be more prevalent among obese persons.
262 +)-MSNs (iMSNs) with dMSNs and indicate that D2R signaling in MSNs is critical for the function of in
265 opaminergic neurons (DA-D2RKO), we show that D2R signaling in MSNs is required and permissive for the
267 ed by Gs-DREADD stimulation, suggesting that D2R activation elicits the ADP by stimulating cAMP/PKA s
268 cking those interactions of dopamine and the D2R that are crucial for an active state, leading to the
271 to a reward-predicting cue, whereas both the D2R and D1R types modulate responses of neurons proximal
273 modeling provided a structural basis for the D2R selectivity of 1, illustrating how subtle difference
279 tionnaires and underwent PET scans using the D2R-selective and nondisplaceable radioligand (N-[(11)C]
283 These findings indicate that DA, through D2R activation in iMSNs, regulates motor output by const
284 geting viral binding and viral entry through D2R- and clathrin-associated mechanisms, respectively.
287 above the control mean, serum antibodies to D2R or NR1 were detected in 8 of 43 psychotic patients b
292 nisms that have classically been ascribed to D2Rs.SIGNIFICANCE STATEMENT Dopamine D2 receptors (D2Rs)
293 of all D2-like receptors, including the two D2R isoforms and the most common D4R polymorphic variant
295 l deficits observed in mice with upregulated D2Rs (D2R-OEdev mice) are reversed by decreasing functio
296 ith positron emission tomography (PET) using D2R radiotracers combined with psychostimulant challenge
297 file: D3R Ki = 6.84 nM, 1700-fold D3R versus D2R binding selectivity, and its metabolic stability in
298 ng in D2+ MSNs is under basal inhibition via D2R/Gi/o and a DA dip leads to a PKA increase by disinhi
300 , we described a new mechanism through which D2R activation can enhance the excitability of pyramidal
301 s unusual physiological phenomenon, in which D2Rs enhance cellular excitability in a manner that depe
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。